Ticker

Analyst Price Targets — ADGM

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
April 14, 2026 9:17 amPiper Sandler$3.00$1.33TheFly Adagio Medical initiated with an Overweight at Piper Sandler

Latest News for ADGM

Sensus Healthcare (NASDAQ:SRTS) versus Adagio Medical (NASDAQ:ADGM) Head to Head Contrast

Sensus Healthcare (NASDAQ: SRTS - Get Free Report) and Adagio Medical (NASDAQ: ADGM - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk. Earnings and Valuation This table compares Sensus

Defense World • Apr 17, 2026
Adagio Medical's ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that its Ultra-low Temperature Ablation technologies (ULTA) for the treatment of scar-related ventricular tachycardia will be featured in several presentations at the Heart Rhythm Society's 47th…

Business Wire • Apr 16, 2026
Short Interest in Adagio Medical Holdings, Inc. (NASDAQ:ADGM) Rises By 60.0%

Adagio Medical Holdings, Inc. (NASDAQ: ADGM - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 24,396 shares, an increase of 60.0% from the March 15th total of 15,249 shares. Currently, 0.1% of the company's stock are short

Defense World • Apr 14, 2026
Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to expand the Company's FULCRUM-VT trial to evaluate the safety and effectiveness of…

Business Wire • Apr 8, 2026
Adagio Medical to Participate in the 25th Annual Needham Virtual Conference

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be participating at the 25th Annual Needham Virtual Conference being held April 13-16, 2026. About Adagio Medical Holdings, Inc. Adagio is a medical device company focused…

Business Wire • Apr 6, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for ADGM.

No House trades found for ADGM.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top